News, reviews and podcasts from annual scientific meetings and symposiums around the world.
A phase III clinical trial of 4,805 women with HER2-positive breast cancer suggests adding a…
About 50% of all cancer survivors and 70% of young breast cancer survivors report moderate…
In one of the first large studies to explore the possible impact of HPV vaccination…
Scientists may have developed the first targeted, oral, tumour-type agnostic therapy – a cancer medicine…
A clinical trial of nearly 2,000 men shows that adding abiraterone acetate (Zytiga) to a…
A randomized clinical trial of 766 patients shows that a simple intervention ̶ a web-based…
After surgery for lymph-node positive colon cancer (stage III), some patients may only need half of…
Findings from a phase III clinical trial of about 300 women may introduce PARP inhibitors…
In an early clinical trial, 33 out of 35 (94%) patients had clinical remission of multiple myeloma upon receiving a new type of…
Advanced cancer triggers enormous distress and brings challenges that can seem overwhelming. Yet, most cancer…